Drugs / Lyme Disease Vaccine Recombinant OspA
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00034086 Background | ? → Jun 2006 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lyme Disease Vaccine Recombinant OspA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00034086 ↗ |
| Modality | Vaccine | “lyme vaccine, polyvalent” NCT00034086 ↗ |